Bone marrow mononuclear cells and acute myocardial infarction

Stem Cell Research and Therapy

Volumn 3, Issue 1, 2012, Pages

  Arnous, Samer ^a   Mozid, Abdul ^a   Martin, John ^a   Mathur, Anthony ^b  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ANGIOGENESIS; BONE MARROW CELL; CELL FUNCTION; CELL HOMING; CELL TRANSDIFFERENTIATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MONONUCLEAR CELL; NONHUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; ACUTE DISEASE; ANIMAL; CLINICAL TRIAL (TOPIC); CYTOLOGY; HEART INFARCTION; HEART VENTRICLE; PATHOPHYSIOLOGY;

ANIMALIA;

ACUTE DISEASE; ANIMALS; BONE MARROW CELLS; CLINICAL TRIALS AS TOPIC; HEART VENTRICLES; HUMANS; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION;

EID: 84862951886     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt93     Document Type: Review

References (101)

1. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. Pfeffer M, John J, McMurray M, Velazquez E, Rouleau J, N Engl J Med 2003 349 1893 1906 10.1056/NEJMoa032292 14610160 (Pubitemid 37409706)
2. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. Braunwald E, N Engl J Med 1997 337 1360 1369 10.1056/NEJM199711063371906 9358131 (Pubitemid 27467771)
3. Stem cells and repair of the heart. Mathur A, Martin JF, Lancet 2004 364 183 192 10.1016/S0140-6736(04)16632-4 15246732 (Pubitemid 38898735)
4. Transdifferentiation of human peripheral blood CD34+ enriched cell population into cardiomyocytes, endothelial cell and smooth muscle cells in vivo. Yeh TH, Zhang S, Wu H, Circulation 2003 108 2070 2073 10.1161/01.CIR. 0000099501.52718.70 14568894 (Pubitemid 37337581)
5. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Badorff C, Circulation 2003 107 1024 1032 10.1161/01.CIR.0000051460.85800.BB 12600917 (Pubitemid 36258727)
6. Non-haematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Kawada H, Fujita J, Kinjo K, Blood 2004 104 3581 3587 10.1182/blood-2004-04-1488 15297308 (Pubitemid 39564430)
7. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Orlic D, Proc Natl Acad Sci USA 2001 98 10344 10349 10.1073/pnas.181177898 11504914 (Pubitemid 32803022)
8. Bone marrow cells regenerate infarcted myocardium. Orlic D, Kajstrua J, Chimenti S, Nature 2001 410 701 705 10.1038/35070587 11287958 (Pubitemid 32290358)
9. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Strauer B, Brehm M, Zeus T, Circulation 2002 106 1913 1918 10.1161/01.CIR.0000034046.87607.1C 12370212 (Pubitemid 35176294)
10. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Assmus B, Schächinger V, Teupe C, Circulation 2002 106 3009 3017 10.1161/01.CIR.0000043246.74879.CD 12473544 (Pubitemid 35440281)
11. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one year results of the TOPCARE-AMI trial. Schächinger V, Assmus B, Britten M, J Am Coll Cardiol 2004 44 1690 1699 10.1016/j.jacc.2004.08.014 15489105 (Pubitemid 39369805)
12. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K, N Engl J Med 2006 355 1199 1209 10.1056/NEJMoa055706 16990383 (Pubitemid 44427444)
13. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S, Eur Heart J 2007 28 766 772 10.1093/eurheartj/ehl509 17298974 (Pubitemid 46439231)
14. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Wollert K, Meyer G, Joachim L, Lancet 2004 364 141 148 10.1016/S0140-6736(04)16626-9 15246726 (Pubitemid 38891685)
15. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Yousef M, Schannwell CM, Kostering M, Zeus T, Brehm M, Strauer BE, J Am Coll Cardiol 2009 53 2262 2269 10.1016/j.jacc.2009.02.051 19520249
16. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Ge J, Qian J, Heart 2006 92 1764 1767 10.1136/hrt.2005.085431 16775089 (Pubitemid 44851319)
17. Intracoronary bone marrow derived progenitor cells in acute infarction. Schächinger V, Erbs S, Elsässer A, REPAIR-AMI investigators, N Engl J Med 2006 355 1210 1221 10.1056/NEJMoa060186 16990384 (Pubitemid 44427445)
18. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators, Eur Heart J 2006 27 2775 2783 10.1093/eurheartj/ehl388 17098754 (Pubitemid 44871463)
19. Autologous bone marrow derived stem cell transfer in patients with ST-segment elevation myocardial infarction: double blind randomised controlled trial. Janssens S, Dubois C, Bogaert J, Lancet 2006 367 113 121 10.1016/S0140-6736(05)67861-0 16413875 (Pubitemid 43077127)
20. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Tendera M, Wojakowski W, Ruzyo W, Chojnowska L, Kepka C, Tracz W, Musiaek P, Piwowarska W, Nessler J, Buszman P, Grajek S, Breborowicz P, Majka M, Ratajczak MZ, REGENT Investigators, Eur Heart J 2009 30 1313 1321 10.1093/eurheartj/ehp073 19208649
21. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Piek JJ, Zijlstra F, HEBE Investigators, Eur Heart J 2011 32 1736 1747 10.1093/eurheartj/ehq449 21148540
22. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM, Eur Heart J 2008 29 1807 1818 10.1093/eurheartj/ehn220 18523058
23. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. Lipinski JM, Giuseppe GL, Zoccai B, Abbate A, Khianey R, J Am Coll Cardiol 2007 50 1761 1767 10.1016/j.jacc.2007.07. 041 17964040 (Pubitemid 47600592)
24. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B, Arch Intern Med 2007 167 989 997 10.1001/archinte.167.10.989 17533201 (Pubitemid 46835786)
25. Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. Reffelmann T, Konemann S, Kloner RA, J Am Coll Cardiol 2009 53 305 308 10.1016/j.jacc.2008.10.018 19161877
26. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ, Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators, N Engl J Med 2002 346 957 966 10.1056/NEJMoa013404 11919304 (Pubitemid 34983245)
27. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansiéri M, Choussat R, Pinton P, ADMIRAL Investigators. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up, N Engl J Med 2001 344 1895 1903 10.1056/NEJM200106213442503 11419426 (Pubitemid 32553358)
28. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. Curtis JP, Sokol SI, Wang Y, Rathore SS, Ko DT, Jadbabaie F, Portnay EL, Marshalko SJ, Radford MJ, Krumholz HM, J Am Coll Cardiol 2003 42 736 742 10.1016/S0735-1097(03)00789-7 12932612 (Pubitemid 37000196)
29. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Tribouilloy C, Rusinaru D, Mahjoub H, Soulière V, Lévy F, Peltier M, Slama M, Massy Z, Eur Heart J 2008 29 339 347 10.1093/eurheartj/ehm554 18156618 (Pubitemid 351197754)
30. Adult stem cells in the treatment of acute myocardial infarction. Sharif F, Bartunek J, Vanderheyden M, Catheter Cardiovasc Interv 2011 77 72 83 10.1002/ccd.22620 20506335
31. Randomized controlled trial on the cardioprotective effect of bone marrow cells in patients undergoing coronary bypass graft surgery. Lai VK, Ang KL, Rathbone W, Harvey NJ, Galinanes M, Eur Heart J 2009 30 2354 2359 10.1093/eurheartj/ehp262 19561024
32. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Oh H, Proc Natl Acad Sci USA 2003 100 12313 12318 10.1073/pnas.2132126100 14530411 (Pubitemid 37271557)
33. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Murry C, Soonpaa M, Reinecke H, Nature 2004 428 664 668 10.1038/nature02446 15034593 (Pubitemid 38524810)
34. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Balsam L, Wagers A, Christensen J, Nature 2004 428 668 673 10.1038/nature02460 15034594 (Pubitemid 38524811)
35. Mesenchymal stem cells as trophic mediators. Caplan AI, Dennis JE, J Cell Biochem 2006 98 1076 1084 10.1002/jcb.20886 16619257 (Pubitemid 44128350)
36. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE, Circ Res 2004 94 678 685 10.1161/01.RES.0000118601.37875.AC 14739163 (Pubitemid 38387752)
37. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Takahashi M, Li TS, Suzuki R, Kobayashi T, Ito H, Ikeda Y, Matsuzaki M, Hamano K, Am J Physiol Heart Circ Physiol 2006 291 886 H893 10.1152/ajpheart. 00142.2006 16603697 (Pubitemid 44175098)
38. Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans. Kubal C, Sheth K, Nadal-Ginard B, Galinanes M, J Thorac Cardiovasc Surg 2006 132 1112 1118 10.1016/j.jtcvs.2006.06.028 17059931 (Pubitemid 44584957)
39. Time-related normalization of maximal coronary flow in isolated perfused hearts of rats with myocardial infarction. Nelissen-Vrancken H, Debets J, Snoeckx L, Daemen M, Smits J, Circulation 1996 93 349 355 8548909 (Pubitemid 26031495)
40. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Takahashi T, Kalka C, Masuda H, Nat Med 1999 5 434 438 10.1038/7434 10202935 (Pubitemid 29180584)
41. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Kalka C, Masuda H, Takahashi T, Proc Natl Acad Sci USA 2000 97 3422 3427 10.1073/pnas.070046397 10725398 (Pubitemid 30183318)
42. Therapeutic angiogenesis in ischemic limbs. Folkman J, Circulation 1998 97 1108 1110 9537334 (Pubitemid 28152881)
43. Isolation of putative progenitor cells for endothelial angiogenesis. Asahara T, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076 (Pubitemid 27087709)
44. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. Isner J, Asahara T, J Clin Invest 1999 103 1231 1236 10.1172/JCI6889 10225965 (Pubitemid 29218292)
45. Myocyte and myogenic stem cell transplantation in the heart. Dowell JD, Rubart M, Pasumarthi KBS, Soonpaa MH, Field LJ, Cardiovasc Res 2003 58 336 350 10.1016/S0008-6363(03)00254-2 12757868 (Pubitemid 36570392)
46. Neovascularization of ischemic myocardium by human bonemarrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Kocher A, Nat Med 2001 7 430 436 10.1038/86498 11283669 (Pubitemid 32298545)
47. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T, Circulation 2001 103 634 637 11156872 (Pubitemid 32144189)
48. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Urbich C, Heeschen C, Aicher A, Dembach E, Zeiher AM, Dimmeler S, Circulation 2003 108 2511 2516 10.1161/01.CIR.0000096483.29777.50 14581410 (Pubitemid 37444414)
49. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S, Nat Med 2003 9 1370 1376 10.1038/nm948 14556003 (Pubitemid 37466185)
50. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischaemia. Fuchs S, Baffour R, Zhou Y, J Am Coll Cardiol 2001 37 1726 1732 10.1016/S0735-1097(01)01200-1 11345391 (Pubitemid 32386014)
51. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Hamano K, Li TS, Kobayashi T, Hirata K, Yano M, Kohno M, Matsuzaki M, Ann Thorac Surg 2002 73 1210 1215 10.1016/S0003-4975(02)03373-8 11996265 (Pubitemid 34279405)
52. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Kamihata H, Matsubara H, Nishiue T, Arterioscler Thromb Vasc Biol 2002 22 1804 1810 10.1161/01.ATV.0000039168.95670.B9 12426208 (Pubitemid 35315765)
53. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Kamihata H, Matsubara H, Nishiue T, Circulation 2001 104 1046 1052 10.1161/hc3501.093817 11524400 (Pubitemid 32803883)
54. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. Jackson K, J Clin Invest 2001 107 1395 1402 10.1172/JCI12150 11390421 (Pubitemid 32522033)
55. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Rehman J, Li J, Orschell CM, March KL, Circulation 2003 107 1164 1169 10.1161/01.CIR. 0000058702.69484.A0 12615796 (Pubitemid 36297209)
56. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Shintani S, Murohara T, Ikeda H, Circulation 2001 103 2776 2779 10.1161/hc2301.092122 11401930 (Pubitemid 32550062)
57. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Iwaguro H, Yamaguchi J, Kalka C, Circulation 2002 105 732 738 10.1161/hc0602.103673 11839630 (Pubitemid 34157378)
58. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Perin E, Circulation 2003 107 2294 2302 10.1161/01.CIR.0000070596.30552.8B 12707230 (Pubitemid 36578498)
59. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. Beauchamp J, Morgan J, Pagel C, Partridge T, J Cell Biol 1999 144 1113 1122 10.1083/jcb.144.6.1113 10087257 (Pubitemid 29157292)
60. Bone marrow homing: the players, the playfield, and their evolving roles. Papayannopoulou T, Curr Opin Hematol 2003 10 214 219 10.1097/00062752- 200305000-00004 12690289 (Pubitemid 36528977)
61. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Aicher A, Circulation 2003 107 2134 2139 10.1161/01.CIR.0000062649.63838.C9 12695305 (Pubitemid 36532196)
62. Sdf-1 involvement in endothelial phenotype and ischemiainduced recruitment of bone marrow progenitor cells. De Falco E, Blood 2004 104 3472 3482 10.1182/blood-2003-12-4423 15284120 (Pubitemid 39564415)
63. Role of b2-integrins for homing and neovascularization capacity of endothelial progenitor cells. Chavakis E, J Exp Med 2005 201 63 72 10.1084/jem.20041402 15623573 (Pubitemid 40130084)
64. Multistep nature of microvascular recruitment of ex vivoexpanded embryonic endothelial progenitor cells during tumor angiogenesis. Vajkoczy P, J Exp Med 2003 197 1755 1765 10.1084/jem.20021659 12810693 (Pubitemid 36745350)
65. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Askari A, Lancet 2003 362 697 703 10.1016/S0140-6736(03)14232-8 12957092 (Pubitemid 37101067)
66. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Yamaguchi J, Circulation 2003 107 1322 1328 10.1161/01.CIR.0000055313.77510.22 12628955 (Pubitemid 36314418)
67. Release of chromatin protein hmgb1 by necrotic cells triggers inflammation. Scaffidi P, Misteli T, Bianchi M, Nature 2002 418 191 195 10.1038/nature00858 12110890 (Pubitemid 34773774)
68. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A, Weber C, Circ Res 2007 100 590 597 10.1161/01.RES.0000259043.42571.68 17272812 (Pubitemid 46673269)
69. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ, J Clin Invest 2003 111 187 196 12531874 (Pubitemid 36105917)
70. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T, Nat Immunol 2002 3 687 694 10.1038/ni813 12068293 (Pubitemid 34752479)
71. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T, Circulation 2003 107 1322 1328 10.1161/01.CIR. 0000055313.77510.22 12628955 (Pubitemid 36314418)
72. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Bartunek J, Dimmeler S, Drexler H, Fernández- Avilés F, Galinanes M, Janssens S, Martin J, Mathur A, Menasche P, Priori S, Strauer B, Tendera M, Wijns W, Zeiher A, task force of the European Society of Cardiology, Eur Heart J 2006 27 1338 1340 10.1093/eurheartj/ehi793 16543252 (Pubitemid 43998109)
73. "Stemness": transcriptional profiling of embryonic and adult stem cells. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan R, Melton D, Science 2002 298 597 600 10.1126/science.1072530 12228720 (Pubitemid 35215313)
74. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Jiang S, Haider HK, Idris NM, Salim A, Ashraf M, Circ Res 2006 99 776 784 10.1161/01.RES.0000244687.97719.4f 16960098 (Pubitemid 44498311)
75. GFP-transduced CD34+ and Lin- CD34- hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct. Norol F, Bonnet N, Peinnequin A, Chretien F, Legrand R, Isnard R, Herodin F, Baillou C, Delache B, Negre D, Klatzmann D, Vernant JP, Lemoine FM, Exp Hematol 2007 35 653 661 10.1016/j.exphem.2006.12.003 17379075 (Pubitemid 46427959)
76. Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cells. Nakamura Y, Wang X, Xu C, Asakura A, Yoshiyama M, From AH, Zhang J, Stem Cells 2007 25 612 620 17095707 (Pubitemid 46354219)
77. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Heeschen C, Circulation 2004 109 1615 1622 10.1161/01.CIR.0000124476.32871.E3 15037527 (Pubitemid 38451717)
78. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Vasa M, Circ Res 2001 89 1 E7 10.1161/hh1301.093953 11440984
79. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. Hill J, N Engl J Med 2003 348 593 600 10.1056/NEJMoa022287 12584367 (Pubitemid 36204953)
80. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Edelberg J, Tang L, Hattori K, Lyden D, Rafii S, Circ Res 2002 90 89 E93 10.1161/01.RES.0000020861.20064.7E 12039806
81. Cardiac stem cell and myocyte aging, heart failure, and insulinlike growth factor-1 overexpression. Torella D, Circ Res 2004 94 514 524 10.1161/01.RES.0000117306.10142.50 14726476 (Pubitemid 38326287)
82. Hmg-coa reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Assmus B, Circ Res 2003 92 1049 1055 10.1161/01.RES.0000070067.64040.7C 12676819 (Pubitemid 36588505)
83. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor trf2 in endothelial progenitor cells. Spyridopoulos I, Circulation 2004 110 3136 3142 10.1161/01.CIR.0000142866.50300.EB 15520325 (Pubitemid 39492010)
84. Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation. Hong SJ, Choi SC, Kim JS, Shim WJ, Park SM, Ahn CM, Park JH, Kim YH, Lim DS, Heart 2010 96 756 764 10.1136/hrt.2009.182683 20448126
85. The role of stem cells in cardiac regeneration. Smits AM, van VP, Hassink RJ, Goumans MJ, Doevendans PA, J Cell Mol Med 2005 9 25 36 10.1111/j.1582-4934. 2005.tb00334.x 15784162
86. Can stem cells mend a broken heart? Davani S, Deschaseaux F, Chalmers D, Tiberghien P, Kantelip JP, Cardiovasc Res 2005 65 305 316 10.1016/j.cardiores. 2004.10.037 15639469 (Pubitemid 40082472)
87. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Planat-Benard V, Circ Res 2004 94 223 229 10.1161/01.RES.0000109792. 43271.47 14656930 (Pubitemid 38197455)
88. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Jiang Y, Exp Hematol 2002 30 896 904 10.1016/S0301-472X(02)00869-X 12160841 (Pubitemid 34845893)
89. Pluripotency of mesenchymal stem cells derived from adult marrow. Jiang Y, Nature 2002 418 41 49 10.1038/nature00870 12077603 (Pubitemid 34742565)
90. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. Kogler G, J Exp Med 2004 200 123 135 10.1084/jem.20040440 15263023 (Pubitemid 38982172)
91. Adult cardiac stem cells are multipotent and support myocardial regeneration. Beltrami A, Cell 2003 114 763 776 10.1016/S0092-8674(03)00687-1 14505575 (Pubitemid 37186770)
92. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
93. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. Meluzin J, Mayer J, Groch L, Am Heart J 2006 152 975.e9 975.e15 10.1016/j.ahj.2006.04.022 17161060 (Pubitemid 43974746)
94. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Fernández-Avilés F, San Román JA, García-Frade J, Fernández ME, Pẽarrubia MJ, de la Fuente L, Gámez-Bueno M, Cantalapiedra A, Fernández J, Gutierrez O, Sánchez PL, Hernández C, Sanz R, García-Sancho J, Sánchez A, Circ Res 2004 95 742 748 10.1161/01.RES.0000144798.54040. ed 15358665 (Pubitemid 39331935)
95. Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function. De Lezo J, Herrera C, Pan M, Rev Esp Cardiol 2007 60 357 365 17521544 (Pubitemid 46881541)
96. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction. Zhan-quan L, Ming Z, Int J Cardiol 2007 115 52 56 10.1016/j.ijcard.2006.04.005 16822566 (Pubitemid 44855191)
97. Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated mTc-MIBI single-photon emission computed tomography study. Lipiec P, Pakula M, Plewka M, Eur J Nucl Mol Imaging 2009 36 587 593 10.1007/s00259-008-0988-6
98. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restonosis after thrombolytic therapy of acute myocardial infarction. Huikuri H, Kervinen K, Niemelä M, Eur Heart J 2008 29 2723 2732 10.1093/eurheartj/ehn436 18845667
99. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocytecolony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Kang H, Kim H, Zhang S, Park K, Cho H, Koo B, Lancet 2004 363 751 756 10.1016/S0140-6736(04)15689-4 15016484 (Pubitemid 38315164)
100. Intracoronary injection of CD133 positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Bartunek J, Vanderheyden M, Vandekerckhove B, Circulation 2005 112 (Suppl 9) 178 I183
101. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP, Am J Cardiol 2004 94 92 95 10.1016/j.amjcard.2004. 03.034 15219514 (Pubitemid 38813459)